The pattern of atrophy in familial Alzheimer disease
Open Access
- 15 October 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (16) , 1425-1433
Abstract
Objective: To assess regional patterns of gray and white matter atrophy in familial Alzheimer disease (FAD) mutation carriers. Methods: A total of 192 participants with volumetric T1-weighted MRI, genotyping, and clinical diagnosis were available from the Dominantly Inherited Alzheimer Network. Of these, 69 were presymptomatic mutation carriers, 50 were symptomatic carriers (31 with Clinical Dementia Rating [CDR] = 0.5, 19 with CDR > 0.5), and 73 were noncarriers from the same families. Voxel-based morphometry was used to identify cross-sectional group differences in gray matter and white matter volume. Results: Significant differences in gray matter (p < 0.05, family-wise error–corrected) were observed between noncarriers and mildly symptomatic (CDR = 0.5) carriers in the thalamus and putamen, as well as in the temporal lobe, precuneus, and cingulate gyrus; the same pattern, but with more extensive changes, was seen in those with CDR > 0.5. Significant white matter differences between noncarriers and symptomatic carriers were observed in the cingulum and fornix; these form input and output connections to the medial temporal lobe, cingulate, and precuneus. No differences between noncarriers and presymptomatic carriers survived correction for multiple comparisons, but there was a trend for decreased gray matter in the thalamus for carriers closer to their estimated age at onset. There were no significant increases of gray or white matter in asymptomatic or symptomatic carriers compared to noncarriers. Conclusions: Atrophy in FAD is observed early, both in areas commonly associated with sporadic Alzheimer disease and also in the putamen and thalamus, 2 regions associated with early amyloid deposition in FAD mutation carriers.Keywords
This publication has 37 references indexed in Scilit:
- Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer’s diseaseBrain, 2013
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- Amyloid-β–Associated Clinical Decline Occurs Only in the Presence of Elevated P-tauArchives of Neurology, 2012
- The mechanism of γ‐Secretase dysfunction in familial Alzheimer diseaseThe EMBO Journal, 2012
- Cortical and Hippocampal Atrophy in Patients with Autosomal Dominant Familial Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2011
- Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm ShiftNeuron, 2011
- Everything You Never Wanted to Know about Circular Analysis, but Were Afraid to AskJournal of Cerebral Blood Flow & Metabolism, 2010
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled TrialJAMA, 2009
- Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI studyBrain, 2008
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methodsJournal of Magnetic Resonance Imaging, 2008